Study Reveals Impact of Acute Kidney Injury Timing on VA-ECMO Outcomes
Research indicates that the timing of acute kidney injury may influence mortality rates in patients undergoing veno-arterial extracorporeal membrane oxygenation.
47.1% of patients developed acute kidney injury before ECMO initiation.
Unadjusted ICU mortality was higher for patients with pre-ECMO AKI at 82.7%.
The timing of AKI should inform ECMO candidacy but is not an independent mortality predictor.
A recent study has highlighted the significance of the timing of acute kidney injury (AKI) in relation to outcomes for adults receiving veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Conducted across two centers in Thailand, the research found that patients who developed AKI prior to ECMO initiation exhibited higher unadjusted mortality rates in the intensive care unit (ICU). However, this correlation diminished after adjusting for various patient characteristics and illness severity, underscoring the necessity of a comprehensive clinical evaluation when determining patient outcomes.
The study analyzed a retrospective cohort of 172 adults who underwent VA-ECMO, categorizing them based on the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Among the participants, 81 patients (47.1%) experienced AKI before the initiation of ECMO, while 82 patients (47.7%) developed AKI afterward. Only nine individuals (5.2%) did not suffer from AKI at any point. This investigation aimed to ascertain whether the timing of renal injury could provide independent prognostic insights for patients requiring this advanced circulatory support.
Patients who developed AKI before ECMO presented with more severe renal dysfunction and had a higher need for renal replacement therapy compared to those who experienced AKI after ECMO initiation. Additionally, acute liver injury was more prevalent in the pre-ECMO group. The unadjusted ICU mortality rate for patients with pre-ECMO AKI was reported at 82.7%, in contrast to 69.5% for those with post-ECMO AKI, with a statistically significant p-value of 0.048. However, this association weakened significantly after adjusting for factors such as age, sex, and chronic kidney disease.
The implications of these findings are critical for evaluating candidates for ECMO. The presence of AKI prior to ECMO may indicate not only renal impairment but also underlying conditions such as pre-cannulation shock and multi-organ dysfunction. This distinction is vital, as the observed mortality differences may reflect the severity of the patients' overall health rather than solely the timing of kidney injury.
In conclusion, while the timing of AKI should be a factor in assessing ECMO candidacy, it should not be the sole determinant for limiting treatment access. The researchers advocate for further studies to clarify the independent prognostic significance of AKI timing in this patient demographic.
